The following lectures are produced by HSF and are eligible for Continuing Medical Education (CME) credit. Click the links below to register for the lectures and claim your CME credit.

Register for Lecture(s)    *Claim CME

*When claiming CME, you will need to claim each lecture separately.

---

Critical Moments in HS: Managing HS for Emergency & Urgent Care Clinicians:

Did you know HS can flare within hours? What can you do to treat a flare now - and reduce the chance of the next one?

Register for Lecture

Disclosures

The Hidradenitis Suppurativa Foundation requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Steve Daveluy Disclosures:

Advisory Board: AbbVie, Novartis, UCB

Consultant: AbbVie, Novartis, UCB, Regeneron

Investigator: Abbvie, Regeneron, UCB, Pfizer, InflaRx

Speaker: AbbVie, Genentech

Joslyn Kirby Disclosures:

Advisory Board: AbbVie, Incyte, Novartis, UCB

Consultant: AbbVie, Alumis, DermTech, Incyte, Insmed, Janssen, Moonlake, Novartis, UCB

Speaker: AbbVie, Janssen, Novartis, UCB

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Pennsylvania Medical Society and the Hidradenitis Suppurativa Foundation.

The Pennsylvania Medical Society is accredited by the ACCME to provide continuing medical education for physicians. The Pennsylvania Medical Society

designates this virtual activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

---

How to Diagnose Hidradenitis Suppurativa:

How can you distinguish HS from MRSA or cellulitis?  Get the latest information on how to diagnose HS!

Register for Lecture

Disclosures

The Hidradenitis Suppurativa Foundation requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Colleen Cotton Disclosures:
Consultant - Pierre-Fabre

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Pennsylvania Medical Society and the Hidradenitis Suppurativa Foundation.

The Pennsylvania Medical Society is accredited by the ACCME to provide continuing medical education for physicians. The Pennsylvania Medical Society

designates this virtual activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

---

First Line Management of Hidradenitis Suppurativa:

How can you make the most of managing your patients with HS?

Register for Lecture

Disclosures

The Hidradenitis Suppurativa Foundation requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Joslyn Kirby Disclosures:

Advisory Board: AbbVie, Incyte, Novartis, UCB

Consultant: AbbVie, Alumis, DermTech, Incyte, Insmed, Janssen, Moonlake, Novartis, UCB

Speaker: AbbVie, Janssen, Novartis, UCB

Tiffany Mayo Disclosures:

Advisory Board: Arcutis, Janssen, Novartis

Clinical Research Grant: Chemocentryx, Eli Lilly, Pfizer

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Pennsylvania Medical Society and the Hidradenitis Suppurativa Foundation.

The Pennsylvania Medical Society is accredited by the ACCME to provide continuing medical education for physicians. The Pennsylvania Medical Society designates this virtual activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.